In the past month, FibroBiologics, Inc. (NASDAQ: FBLG) has disclosed the advancement of its fibroblast therapy platform into additional indications, including: On March 2, 2026, the company announced ...
On May 16, 2025, FibroBiologics, Inc. (NASDAQ:FBLG) announced a poster presentation at the Society for Investigative Dermatology (SID) Annual Meeting. The poster entitled “Immunomodulatory Potential ...
A recent study published in the Nutrients Journal evaluated the effects of phenolic compounds in extra virgin olive oil (EVOO) on the proliferation, cell cycle, migration, and antigenic profile of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results